Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1979
05/08/1979US4153685 As an ammonium carboxylate double salt, with a protein; nondialysable antiulcer agents
05/08/1979US4153683 Ointment for skin disorders
05/08/1979CA1054052A1 Simplified method for preparation of high yield, high purity factor viii concentrate
05/02/1979EP0001684A2 Tetrapeptides, methods for their preparation and their use in analgesic compositions
05/01/1979US4152425 Oligopeptides
05/01/1979US4152322 Process for selective reduction of nitroarginyl peptides with titanium (iii)
05/01/1979US4152209 Nucleotide pyrophosphotransferase and method of preparation
05/01/1979CA1053662A1 Peptide derivatives having an antihypertensive effect and process for their manufacture
05/01/1979CA1053661A1 Protease-free proteins, and methods of manufacturing and using the same
04/1979
04/24/1979US4151276 Method of suppressing gastric acid secretion by the oral administration of calcitonin
04/24/1979CA1053167A1 Desacyl-pepsidine from bacillus pumilus
04/24/1979CA1053150A1 Method of suppressing gastric acid secretion by the oral administration of calcitonin
04/18/1979EP0001449A2 Analogues of somatostatin, pharmaceutical compositions containing them and their preparation
04/18/1979EP0001443A1 Agent for the contraception and termination of pregnancy and process for its production
04/17/1979US4150150 Subjecting tumors to alternating current
04/17/1979US4150121 Kinin containing injection composition
04/17/1979US4150120 Administering thyroid stimulating hormone releasing hormone
04/17/1979US4150118 Snake venom inhibitor
04/17/1979US4150117 Process for the preparation of gastrointestinal hormone
04/17/1979US4150116 Immunization against dental caries with glucosyltransferase antigens
04/17/1979CA1052773A1 P-glu-d-phe-trp-ser-tyr-d-pgl-leu-arg-pro-gly-nh2 and intermediates
04/17/1979CA1052772A1 Peptides for control of intestinal motility
04/17/1979CA1052693A1 Modifying enzymes with polyethylene glycol and product produced thereby
04/10/1979US4149003 Polypeptide thiol couplers
04/10/1979US4148886 Treatment of autoimmune diseases
04/10/1979US4148788 Agent affecting regulation and function of thymus dependent lymphocytes; polypeptide
04/10/1979US4148787 Antidiuretically effective polypeptide and a process for preparing the same
04/10/1979US4148786 Cyclic polypeptides, resin immobilized peptides
04/10/1979US4148785 Analgesic polypeptide
04/10/1979CA1052307A1 Method for the extraction and processing of glycoproteins, mucopolysaccharides and accompanying substances
04/10/1979CA1052306A1 Method for the separation of proteins from viruses and proteins thus obtained
04/04/1979EP0001335A1 A peptide, processes for its preparation and compositions containing the same
04/04/1979EP0001295A2 Somatostatin-like cyclopeptides, a process for their preparation, pharmaceutical compositions containing them, and their therapeutical application
04/03/1979US4147782 Pharmaceutical detergent composition
04/03/1979US4147700 Triazolylbenzophenone derivatives and production thereof
04/03/1979CA1051874A1 L-3-(3,4-dihydroxy-phenyl)-2-methylalanine-peptides
04/03/1979CA1051873A1 Peptides having lh-rh/fsh-rh-activity and process for preparing them
04/03/1979CA1051802A1 Amino acid derivatives and a process for the preparation thereof
04/03/1979CA1051801A1 Bestatin, an enzyme inhibitor from streptomyces
03/1979
03/27/1979US4146613 Oral anti-diabetic drug composition
03/27/1979US4146612 Somatostatin analogs
03/27/1979US4146611 Amino acid derivatives
03/27/1979US4146603 Tumor specific glycoproteins and method for detecting tumorigenic cancers
03/21/1979EP0001174A1 A peptide and the salts thereof, processes for their preparation and compositions containing them
03/21/1979EP0001124A1 Drug mixtures for improving the utilisation of glucose in the cells and to reduce the bloodsugar level
03/21/1979EP0001104A2 Modified intact erythrocytes, blood or blood preserves containing them and process for their preparation
03/21/1979EP0001061A1 Polypeptides, their preparation and pharmaceutical compositions containing them
03/20/1979US4145337 Aminoethylglycine containing polypeptides
03/20/1979CA1050890A1 Amino acid formulations for patients with liver disease and method of using same
03/20/1979CA1050885A1 Method of preparing a protein product and its application
03/13/1979US4144354 Feed containing enzymes
03/13/1979US4144327 Synergistic
03/13/1979US4144228 Methionine5 -enkephalin sulfoxides and sulfones
03/13/1979US4144131 Immobilization of enzymes on human tissue or erythrocytes
03/13/1979CA1050426A1 Process for the production of pharmaceutical composition of insulin for rectal use
03/07/1979EP0000919A1 Somatostatin analogs, process for their preparation and their use in pharmaceuticals.
03/06/1979US4143136 Progestagenic compound, lutenizing hormone release factor
03/06/1979US4143134 Halo-phosphonopeptides
03/06/1979US4143133 Claudogenic-interceptive nonapeptides
03/06/1979US4143048 Amination
03/06/1979CA1049942A1 Enzyme-hormone complex from small intestine
02/1979
02/27/1979US4141972 Purine nucleoside 5'-phosphate (mono, di or tri) 3'(2')-diphosphates and processes for their preparation
02/27/1979US4141901 Process for producing triazolylbenzophenone derivatives
02/27/1979US4141887 Process and apparatus for the production of sterile filtered blood clotting factors
02/27/1979CA1049532A1 Antibiotics
02/27/1979CA1049406A1 Isolation of hemagglutinin and neuraminidase from influenza virus
02/21/1979EP0000764A1 Anticonceptive agent containing a peptide
02/21/1979EP0000741A2 Indolacetoxyacetylaminoacid derivatives, process for their preparation and their use in drugs
02/20/1979US4140767 Growth hormone inhibitors
02/20/1979US4140761 Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
02/20/1979US4140681 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
02/20/1979US4140679 Antigen-protein complex for blocking allergic reactions
02/20/1979CA1048998A1 Chromogenic enzyme substrates
02/13/1979US4139529 N2 -Naphthalenesulfonyl-L-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof
02/13/1979US4139526 Somatostatin analogs
02/13/1979US4139504 Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
02/07/1979EP0000670A1 Therapeutic selenium compositions and the use thereof
02/07/1979EP0000651A1 Method of separating a factor IX preparation from blood plasma
02/07/1979EP0000650A2 Non-activating polyelectrolytes and their use in a method for separation of blood coagulation factors
02/07/1979EP0000559A1 Pentapeptide-N-alkylamides and their acid addition salts, methods for preparation of these compounds and pharmaceutical formulations containing them
02/07/1979EP0000520A1 Improvement in or relating to a process for producing interferon
02/07/1979EP0000486A1 Method for preparing stabilized carrier-bound proteins
02/06/1979CA1047928A1 Effervescent enteric coated l-dopa formulation and method of using the same
02/06/1979CA1047919A1 Pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
01/1979
01/30/1979US4137224 Process for the preparation of antibiotic W-10 complex and for the isolation of antibiotic 20561 and antibiotic 20562 therefrom
01/30/1979US4137222 Protein product, a process for preparation, and application of said product
01/30/1979US4137127 Binding to insolubilized heparin
01/30/1979CA1047485A1 Tripeptides, their esters and amides, and anti-ulcera activity thereof
01/30/1979CA1047422A1 Process of manufacturing enzyme preparation rich in lipase
01/30/1979CA1047403A1 Process for making a monolithic drug delivery device
01/24/1979EP0000330A1 Lipopeptides, process for their preparation and pharmaceutical compositions containing them
01/23/1979US4136168 Process for the preparation of neuraminidase from viral sources and methods of utilizing same
01/23/1979US4136094 Silica treatment, ion exchanging
01/23/1979US4136093 Hemoglobin preparation with increased oxygen release
01/23/1979US4135516 Delivery apparatus and method for treatment of intralenticular cataracts with exogenous enzymes
01/16/1979US4134972 Compositions having antibiotic properties
01/16/1979US4134943 Mixing with solvent, freezing, evaporation
01/16/1979CA1046407A1 Dried particulate animal serum of reduced saline content
01/16/1979CA1046406A1 Compounds of the plasminogen type and method for obtaining such compounds from placental pulps
01/10/1979EP0000252A1 Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides